Cardamonin inhibits COX and iNOS expression via inhibition of p65NF-κB nuclear translocation and Iκ-B phosphorylation in RAW 264.7 macrophage cells

Molecular Immunology

Volumn 44, Issue 5, 2007, Pages 673-679

  Israf, D A ^a   Khaizurin, T A ^a   Syahida, A ^a   Lajis, N H ^a   Khozirah, S ^a  

^a UNIVERSITY PUTRA MALAYSIA   (Malaysia)

Author keywords

Cardamonin; COX 2; I B ; iNOS; NO; p65NF B; PGE2

Indexed keywords

ANTIINFLAMMATORY AGENT; CARDAMONIN; CYCLOOXYGENASE 2; DEXAMETHASONE; GAMMA INTERFERON; I KAPPA B; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; LIPOPOLYSACCHARIDE; PROSTAGLANDIN E2; PROSTAGLANDIN SYNTHASE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DOWN REGULATION; ENZYME ACTIVITY; ENZYME DEGRADATION; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION;

ANIMALS; ANTI-INFLAMMATORY AGENTS; CELL LINE; CHALCONES; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITORS; DINOPROSTONE; DOWN-REGULATION; I-KAPPA B PROTEINS; INTERFERON TYPE II; INTERFERON-GAMMA; LIPOPOLYSACCHARIDES; MICE; NITRIC OXIDE SYNTHASE TYPE II; NITRITES; PHOSPHORYLATION; TRANSCRIPTION FACTOR RELA;

ALPINIA RAFFLESIANA;

EID: 33748758968     PISSN: 01615890     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molimm.2006.04.025     Document Type: Article

References (28)

1. Abate A., Oberle S., and Schröder H. Lipopolysaccharide-induced expression of cyclooxygenase-2 in mouse macrophages is inhibited by chloromethylketones and a direct inhibitor of NF-κB translocation. Prostag. Oth. Lipid M. 56 (1998) 277-290
2. Ahn K.S., Noh E.J., Zhao H.L., Jung S.H., Kang S.S., and Kim Y.S. Inhibition of inducible nitric oxide synthase and cyclooxygenase II by Platycodon grandiflorum saponins via suppression of nuclear factor-κB activation in RAW 264.7 cells. Life Sci. 76 (2005) 2315-2328
3. Bheemasankara R.C., Namosiva R.T., and Suryaprakasam S. Cardamonin and alpinetin from the seeds of Amomum subulatum. Planta Med. 29 (1976) 391-392
4. Bors W., Heller W., Michel C., and Saran M. Flavonoids as antioxidants: determination of radical-scavenging efficiencies. Meth. Enzymol. 186 (1990) 343-355
5. Chen S.C., Chang Y.S., Wang J.P., Chen S.C., and Kuo S.C. Three new flavonoids and antiallergenic, anti-inflammatory constituents from the heartwood of Dalbergia odorifera. Planta Medica 64 (1998) 153-158
6. Folmer F., Blasius R., Morceau F., Tabudravu J., Dicato M., Jaspars M., and Diederich M. Inhibition of TNFa-induced activation of nuclear factor kB by kava (Piper methysticum) derivatives. Biochem. Pharmacol. 71 (2006) 1206-1218
7. Fujihara M., Muroi M., Tanamoto K., Suzuki T., Azuma H., and Ikeda H. Molecular mechanisms of macrophage activation and deactivation by Lipopolysaccharide: roles of the receptor complex. Pharmacol. Therapeut. 100 (2003) 171-194
8. Griscavage J.M., Wilk S., and Ignarro L.J. Inhibitors of the proteasomes pathway interfere with induction of nitric oxide synthase in macrophage by blocking activation of transcription factor NF-κB. Proc. Natl. Acad. Sci. U.S.A. 93 (1996) 3308-3312
9. Jiang X., Takahashi N., Ando K., Otsuka T., Tetsuka T., and Okamoto T. NF-κB p65 transactivation domain is involved in the NF-κB-inducing kinase pathway. Biochem. Biophys. Res. Co. 301 (2003) 583-590
10. Jijon H., Allard B., and Jobin C. NF-κB inducing kinase activates NF-κB transcriptional activity independent of IκB kinase γ through a p38 MAPK-dependent RelA phosphorylation pathway. Cell. Signal. 16 (2004) 1023-1032
11. Kang Y.J., Lee B.K., Lee Y.S., Seo H.G., Park M.K., Kim H.J., Pyo H.S., Chong W.S., Jung H.J., Yun-Choi H.S., Lee D.H., and Chang K.C. Suppression of tumor necrosis factor-α and inducible nitric oxide synthase gene expression by THI 52, a new synthetic naphthyl-benzylisoquinoline alkaloid. Biochem. Pharmacol. 65 (2003) 457-464
12. Kiemer A.K., Hartung T., Huber C., and Vollmar A. Phyllanthus amarus has anti-inflammatory potential by inhibition of iNOS, COX-2, and cytokines via the NF-κB pathway. J. Hepatol. 38 (2003) 289-297
13. Kubatka P., Ahlers I., Ahlersová E., Adámeková E., Luk P., Bojková B., and Marková M. Chemoprevention of mammary carcinogenesis in female rats by rofecoxib. Cancer Lett. 202 (2003) 131-136
14. Lee Y.W., Han S.H., Lee M., Yang K.H., Kim H.M., and Jeon Y.J. 2-Amino-3-methylimidazo[4,5-f]quinoline inhibits nitric oxide production in lipopolysaccharide-stimulated RAW 264 7 cells by blocking p38 kinase activation. Cancer Lett. 156 (2000) 133-139
15. Lee S.H., Lee S.Y., Son D.J., Lee H., Yoo H.S., Song S., Oh K.W., Han D.C., Kwon B.M., and Hong J.T. Inhibitory effect of 2′-hydroxycinnamaldehyde on nitric oxide production through inhibition of NF-κB activation in RAW 264.7 cells. Biochem. Pharmacol. 69 (2005) 791-799
16. Lewis A.J., and Manning A.A. New targets for anti-inflammatory drugs. Curr. Opin. Chem. Biol. 3 (1999) 489-494
17. Liang Y.-C., Huang Y.-T., Tsai S.-H., Lin-Shiau S.-Y., Chen C.-F., and Lin J.-K. Suppression of inducible cyclooxygenase and inducible nitric oxide synthase by apigenin and related flavonoids in mouse macrophages. Carcinogenesis 20 (1999) 1945-1952
18. Makarov S.S. NF-κB as a therapeutic target in chronic inflammation: recent advances. Mol Med Tod. 6 (2000) 441-448
19. Motilva V., de la Lastra C.A., Bruseghini L., Herrerias J.M., and Sánchez-Fidalgo S. COX expression and PGE2 and PGD2 production in experimental acute and chronic gastric lesions. Int. Immunopharmacol. 5 (2005) 369-379
20. Nasuhara Y., Adcock I.M., Catley M., Barnes P.J., and Newton R. Differential IκB kinase activation and IκBα degradation by interleukin-1β and tumor necrosis factor-α in human U937 monocytic cells. J. Biol. Chem. 274 (1999) 19965-19972
21. Okamoto T., Ogiwara H., Hayashi T., Mitsui A., Kawabe T., and Yodoi J. Human thioredoxin/adult T cell leukemia-derived factor activates the enhancer binding protein of human immunodeficiency virus type 1 by thiol redox control mechanism. Int. Immunol. 4 (1992) 811-819
22. Pan M.-H., Lin-Shiau S.-Y., and Lin J.-K. Comparative studies on the suppression of nitric oxide synthase by curcumin and its hydrogenated metabolites through down-regulation of IκB kinase and NFκB activation in macrophages. Biochem. Pharmacol. 60 (2000) 1665-2167
23. Pando M.P., and Verma I.M. Signal-dependent and -independent degradation of free and NF-κB-bound IκBα. J. Biol. Chem. 275 (2000) 21278-21286
24. Rojas J., Payá M., Domínguez J.N., and Ferrández M.L. ttCH, a selective inhibitor of inducible nitric oxide synthase expression with antiarthritic properties. Eur. J. Pharmacol. 465 (2003) 183-189
25. Surh Y., Chun K., Cha H., Han S.S., Keum Y., Park K., and Lee S.S. Molecular mechanisms underlying chemopreventive activities of anti-inflammatory phytochemicals: down-regulation of COX-2 and iNOS through suppression of NF-κB activation. Mutat. Res.-Fund Mol. M 480/481 (2001) 243-268
26. Syahida A., Israf D.A., Lajis N.H., Shaari K., Mohamed H., Afiza A.W., Khaizurin T.A., Hoo W.Y., Nasaruddin A.A., Kadir A.A., Sulaiman M.R., and Somchit M.N. Cardamonin, inhibits pro-inflammatory mediators in activated RAW 264.7 cells and whole blood. Eur. J. Pharmacol. 538 (2006) 188-194
27. Trakoontivakorn G., Nakahara K., Shinmoto H., Takenaka M., Onishi-Kameyama M., Ono H., Yoshida M., Nagata T., and Tsushida T. Structural analysis of a novel antimutagenic compound, 4-hydroxypanduratin A, and the antimutagenic activity of flavonoids in a Thai spice, fingerroot (Boesenbergia pandurata Schult) against mutagenic heterocyclic amines. J. Agric. Food Chem. 49 (2001) 3046-3050
28. Wang Z.T., Lau C.W., Chan F.L., Yao X., Chen Z.Y., He Z.D., and Huang Y. Vasorelaxant effects of cardamonin and alpinetin from Alpinia henryi K. Schum. J. Cardiovascul. Pharmacol. 37 (2001) 596-606